Recent CELL News
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/08/2024 10:58:45 PM
- Form 15-12G - Securities registration termination [Section 12(g)] • Edgar (US Regulatory) • 10/12/2023 01:00:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/03/2023 07:32:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/03/2023 07:24:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/03/2023 06:37:52 PM
- Form POSASR - Post-effective Amendment to an automatic shelf registration statement • Edgar (US Regulatory) • 10/02/2023 09:16:24 PM
- Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 10/02/2023 09:06:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/02/2023 12:47:30 PM
- Form SC 14D9/A - Solicitation, recommendation statements: [Amend] • Edgar (US Regulatory) • 09/29/2023 12:30:27 PM
- PhenomeX Announces Opto® Memory B Discovery Human Workflow on the Beacon® Optofluidic Platform • PR Newswire (US) • 09/27/2023 12:51:00 PM
- PhenomeX Announces the Release of SpotLight™ Human Lambda Reagent for the Beacon® Platform to Accelerate Cell Line Development Workflows • PR Newswire (US) • 09/21/2023 12:35:00 PM
- PhenomeX to Participate in Upcoming Cell Biology Conferences • PR Newswire (US) • 09/20/2023 12:48:00 PM
- Form SC 14D9/A - Solicitation, recommendation statements: [Amend] • Edgar (US Regulatory) • 09/20/2023 10:05:56 AM
- PhenomeX Unveils Meteor™ Chips For Quantitative Bulk Analysis On The IsoSpark™ Platform To Revolutionize High Throughput Multiplexed Hands-Free Proteomics • PR Newswire (US) • 09/15/2023 01:08:00 PM
- PhenomeX Inc. Announces Commencement of Cash Tender Offer by Bruker • PR Newswire (US) • 09/05/2023 08:02:00 PM
- Form SC 14D9 - Solicitation, recommendation statements • Edgar (US Regulatory) • 08/31/2023 08:47:57 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 08/28/2023 09:04:18 PM
- Form SC14D9C - Written communication relating to third party tender offer • Edgar (US Regulatory) • 08/18/2023 09:21:23 PM
- Form SC14D9C - Written communication relating to third party tender offer • Edgar (US Regulatory) • 08/17/2023 09:28:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/17/2023 09:27:26 PM
- Form SC14D9C - Written communication relating to third party tender offer • Edgar (US Regulatory) • 08/17/2023 01:10:44 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM